Success of smoking cessation interventions during pregnancy

American Journal of Obstetrics and Gynecology

Volumn 215, Issue 5, 2016, Pages 611.e1-611.e8

  Bérard, Anick ^a,b   Zhao, Jin Ping ^a,b   Sheehy, Odile ^b  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITY OF MONTREAL   (Canada)

Author keywords

bupropion; nicotine patch replacement; prematurity; small for gestational age; smoking cessation during pregnancy

Indexed keywords

AMFEBUTAMONE; NICOTINE PATCH; DOPAMINE UPTAKE INHIBITOR; NICOTINE; NICOTINE GUM;

ADULT; ARTICLE; ASTHMA; COMORBIDITY; DEPRESSION; DIABETES MELLITUS; FEMALE; HEALTH CARE UTILIZATION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; NICOTINE REPLACEMENT THERAPY; PREGNANCY; PREGNANT WOMAN; PREMATURITY; PRIORITY JOURNAL; QUEBEC; SMALL FOR DATE INFANT; SMOKING CESSATION; SOCIAL STATUS; ADOLESCENT; LONGITUDINAL STUDY; MALE; MIDDLE AGED; NEWBORN; PREGNANCY OUTCOME; PREMATURE BIRTH; PRENATAL CARE; PROCEDURES; RETROSPECTIVE STUDY; RISK FACTOR; STATISTICS AND NUMERICAL DATA; YOUNG ADULT;

ADOLESCENT; ADULT; BUPROPION; DOPAMINE UPTAKE INHIBITORS; FEMALE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, SMALL FOR GESTATIONAL AGE; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NICOTINE; PREGNANCY; PREGNANCY OUTCOME; PREMATURE BIRTH; PRENATAL CARE; RETROSPECTIVE STUDIES; RISK FACTORS; SMOKING CESSATION; TOBACCO USE CESSATION PRODUCTS; YOUNG ADULT;

EID: 84994476120     PISSN: 00029378     EISSN: 10976868     Source Type: Journal    
DOI: 10.1016/j.ajog.2016.06.059     Document Type: Article

References (32)

1. 1 Chan, B., Einarson, A., Koren, G., Effectiveness of bupropion for smoking cessation during pregnancy. J Addict Dis 24 (2005), 19–23.
2. 2 Oncken, C.A., Kranzler, H.R., Pharmacotherapies to enhance smoking cessation during pregnancy. Drug Alcohol Rev 22 (2003), 191–202.
3. 3 Centers for Disease Control and Prevention (CDC). Pregnancy risk assessment monitoring system. 2004, Centers for Disease Control and Prevention, Atlanta (GA).
4. 4 National Health Service. The NHS Information Centre by IFF Research in partnership with Professor Mary Renfrew, Mother and Infant Research Unit, Department of Health Sciences, University of York. 2011. Available at: http://www.ic.nhs.uk/statistics-and-data-collections/health-and-lifestyles-related-surveys/infant-feeding-survey/infant-feeding-survey-2010-early-results. Accessed March 12, 2012.
5. 5 Cnattingius, S., The epidemiology of smoking during pregnancy: smoking prevalence, maternal characteristics, and pregnancy outcomes. Nicotine Tob Res 6:Suppl 2 (2004), S125–S140.
6. 6 World Health Organization. Report on the Global Tobacco Epidemic 2008—the MPOWER package. 2008, World Health Organization, Geneva (Switzerland).
7. 7 Health Canada. Canadian Tobacco Use Monitoring Survey. 2009. Available at: http://www.hc-sc.gc.ca/hc-ps/tobac-tabac/research-recherche/stat/_ctums-esutc_2009/ann-eng.php#t7. Accessed March 12, 2012.
8. 8 Lassen, T.H., Madsen, M., Skovgaard, L.T., Strandberg-Larsen, K., Olsen, J., Andersen, A.M., Maternal use of nicotine replacement therapy during pregnancy and offspring birthweight: a study within the Danish National Birth Cohort. Paediatr Perinat Epidemiol 24 (2010), 272–281.
9. 9 Oncken, C., Dornelas, E., Greene, J., Sankey, H., Glasmann, A., Feinn, R., Kranzler, H.R., Nicotine gum for pregnant smokers: a randomized controlled trial. Obstet Gynecol 112 (2008), 859–867.
10. 10 Fiore, M.C., Bailey, W.C., Cohen, S.J., et al. Clinical practice guideline. Treating Tobacco Use and Dependence. 2000, Public Health Service, US Department of Health and Human Services, Rockville (MD).
11. 11 Kapur, B., Hackman, R., Selby, P., Klein, J.D., Koren, G., Randomized, double-blind, placebo-controlled trial of nicotine replacement therapy in pregnancy. Curr Ther Res 62 (2001), 274–278.
12. 12 Hotham, E.D., Gilbert, A.L., Atkinson, E.R., A randomised-controlled pilot study using nicotine patches with pregnant women. Addict Behav 31 (2006), 641–648.
13. 13 Forinash, A.B., Pitlick, J.M., Clark, K., Alstat, V., Nicotine replacement therapy effect on pregnancy outcomes. Ann Pharmacother 44 (2010), 1817–1821.
14. 14 Rayburn, W.F., Bogenschutz, M.P., Pharmacotherapy for pregnant women with addictions. Am J Obstet Gynecol 191 (2004), 1885–1897.
15. 15 Havard, A., Jorm, L.R., Preen, D., et al. The Smoking MUMS (Maternal Use of Medications and Safety) Study: protocol for a population-based cohort study using linked administrative data. BMJ Open, 3, 2013, e003692.
16. 16 De Long, N.E., Barra, N.G., Hardy, D.B., Holloway, A.C., Is it safe to use smoking cessation therapeutics during pregnancy?. Expert Opin Drug Saf 13 (2014), 1721–1731.
17. 17 Vilain, A., Otis, S., Forget, A., Blais, L., Agreement between administrative databases and medical charts for pregnancy-related variables among asthmatic women. Pharmacoepidemiol Drug Saf 17 (2008), 345–353.
18. 18 Berard, A., Sheehy, O., The Quebec Pregnancy Cohort—prevalence of medication use during gestation and pregnancy outcomes. PLoS One, 9, 2014, e93870.
19. 19 Moussally, K., Oraichi, D., Berard, A., Herbal products use during pregnancy: prevalence and predictors. Pharmacoepidemiol Drug Saf 18 (2009), 454–461.
20. 20 Chaabane, S., Berard, A., Epidemiology of major congenital malformations with specific focus on teratogens. Curr Drug Saf 8 (2013), 128–140.
21. 21 Briggs, G.G., Freeman, R.K., Yaffe, S.J., Drugs in pregnancy and lactation: a reference guide to fetal and neonatal risk. 9th ed., 2011, Lippincott William & Wilkins, New York.
22. 22 Jobin-Gervais, K., Sheehy, O., Berard, A., Can we rely on pharmacy claims databases to ascertain maternal use of medications during pregnancy?. Pharmacoepidemiol Drug Saf, 22, 2013, 155.
23. 23 Kramer, M.S., Platt, R.W., Wen, S.W., et al. A new and improved population-based Canadian reference for birth weight for gestational age. Pediatrics, 108, 2001, E35.
24. 24 Benowitz, N.L., Dempsey, D.A., Goldenberg, R.L., et al. The use of pharmacotherapies for smoking cessation during pregnancy. Tob Control 9:Suppl 3 (2000), III91–III94.
25. 25 Society for the Study of Addiction (treattobacco.net). Treatment guidelines: 2011. Available at: http://www.treatobacco.net/en/page_224.php. Accessed March 16, 2012.
26. 26 Wisborg, K., Henriksen, T.B., Jespersen, L.B., Secher, N.J., Nicotine patches for pregnant smokers: a randomized controlled study. Obstet Gynecol 96 (2000), 967–971.
27. 27 Stead, L.F., Perera, R., Bullen, C., Mant, D., Lancaster, T., Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev, 2008, CD000146.
28. 28 Coleman, T., Chamberlain, C., Davey, M.A., Cooper, S.E., Leonardi-Bee, J., Pharmacological interventions for promoting smoking cessation during pregnancy. Cochrane Database Syst Rev, 2015, CD010078.
29. 29 Pollak, K.I., Oncken, C.A., Lipkus, I.M., et al. Nicotine replacement and behavioral therapy for smoking cessation in pregnancy. Am J Prev Med 33 (2007), 297–305.
30. 30 Coleman, T., Cooper, S., Thornton, J.G., et al. A randomized trial of nicotine-replacement therapy patches in pregnancy. N Engl J Med 366 (2012), 808–818.
31. 31 Clark, S.M., Nakad, R., Pharmacotherapeutic management of nicotine dependence in pregnancy. Obstet Gynecol Clin North Am 38 (2011), 297–311.
32. 32 Chisolm, M.S., Brigham, E.P., Tuten, M., Strain, E.C., Jones, H.E., The relationship between antidepressant use and smoking cessation in pregnant women in treatment for substance abuse. Am J Drug Alcohol Abuse 36 (2010), 46–51.